CLINICAL_TRIALS
trial_result
· 2013-05-31
Clinical Trial Update: PRO 140 by IV Administration in Adults With HIV-1 Infection [Phase 2]
Summary
A Phase 2 clinical trial evaluating intravenous PRO 140 (leronlimab) in adults with HIV-1 infection has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CytoDyn, Inc. | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2013-05-31